Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT01665417Phase 4Unknown
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
AdenocarcinomaEGFR Positive Non-small Cell Lung Cancer
Studydirector

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peking University Cancer Hospital & Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Liu Wei, MD

Hebei Provincal Tumor Hospital

Related
1 trials

Shared therapeutic areas:

AdenocarcinomaEGFR Positive Non-small Cell Lung Cancer

Worked with same sponsors:

Betta Pharmaceuticals Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Jiao Shunchang, MD

Chinese People's Liberation Army (PLA) General Hospital

Related
1 trials

Shared therapeutic areas:

AdenocarcinomaEGFR Positive Non-small Cell Lung Cancer

Worked with same sponsors:

Betta Pharmaceuticals Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Bai Chunmei, MD

Peking Union Medical College Hospital

Related
1 trials

Shared therapeutic areas:

AdenocarcinomaEGFR Positive Non-small Cell Lung Cancer

Worked with same sponsors:

Betta Pharmaceuticals Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

James C Yang, M.D.

National Cancer Institute (NCI)

Related
7 trials

Shared therapeutic areas:

Adenocarcinoma
Similarity Score15%

Nataliya Uboha, MD, PhD

University of Wisconsin, Madison

Related
3 trials

Shared therapeutic areas:

Adenocarcinoma
Similarity Score15%

Per Pfeiffer, Professor

Odense University Hospital

Related
3 trials

Shared therapeutic areas:

Adenocarcinoma
Similarity Score15%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Adenocarcinoma
Similarity Score15%

Philippe Bedard, M.D.

Princess Margaret Cancer Centre

Related
4 trials

Shared therapeutic areas:

Adenocarcinoma
Similarity Score15%

Andrea Hayes-Jordan, MD

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Adenocarcinoma
Similarity Score15%

Cary Presant, MD

Pierian Biosciences

Related
3 trials

Shared therapeutic areas:

Adenocarcinoma
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01665417Phase 4StudyDirector

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

AdenocarcinomaEGFR Positive Non-small Cell Lung Cancer
Unknown

All 1 trials loaded